Johnson & Johnson is highlighted as a strong low volatility blue chip stock, with optimistic price targets from Citi and Goldman Sachs. Growth is expected from its Innovative Medicines and MedTech sectors, though some AI stocks may provide faster returns.

NodeGuardian

2026-04-17 16:10:08

Abstract generation in progress

Johnson & Johnson (JNJ) has been identified as a top low volatility blue chip stock, with recent positive price target updates from Citi and Goldman Sachs ahead of its Q1 earnings. Analysts anticipate growth driven by the Innovative Medicines business and MedTech stabilization, alongside new product cycles. Despite acknowledging JNJ’s investment potential, the article suggests that some AI stocks may offer higher and quicker returns for investors.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
189.98K Popularity
#
Gate13thAnniversaryLive
657.28K Popularity
#
AltcoinsRallyStrong
7.31M Popularity
#
AnthropicvsOpenAIHeatsUp
1.06M Popularity
#
KalshiFacesNevadaRegulatoryClash
459.31K Popularity

Sitemap

Here is Why Johnson & Johnson (JNJ) Ranks Among the 15 Best Low Volatility Blue Chip Stocks to Buy Now

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

AltcoinsRallyStrong

AnthropicvsOpenAIHeatsUp

KalshiFacesNevadaRegulatoryClash

Pin